February 16, 2023
The clinical partnerships, focused on expanding the clinical utility of the Promaxo MRI to kidney cancers, pelvic floor abnormalities and prostate ablative treatments with gold nanoparticles, are being announced in conjunction with the ongoing American Society of Clinical Oncology Genitourinary Cancers (ASCO – GU) Symposium in San Francisco, CA, where Promaxo is hosting meetings with the GU-community.
February 1, 2023
Promaxo, Inc. today announced five Promaxo systems sold in the month of January 2023, for a total of 30 MRIs and approximately $18.3 million in sales achieved since the Company’s commercial launch in the fourth quarter of 2021. Promaxo systems were sold to: Mount Sinai Health System, NY; UTHealth Houston, The University of Texas Health Science Center at Houston, TX; Urology Care of Central New Jersey, NJ; Yalkut Urology, KY; and University Hospital Tuebingen, Germany.
January 12, 2023
Promaxo is available to meet with investors at the conference; please request a meeting through the conference site at https://brileyoncology22.sequireevents.com/.
January 9, 2023
In the fourth quarter, in addition to entering into commercial agreements with three more urology groups in the state of Florida, Promaxo expanded its commercial footprint in Ohio, New York City and South Carolina. The commercial partnerships include agreements with two practices from GenesisCare (https://www.genesiscare.com/), and a sale to Cleveland Urology Associates.
December 20, 2022
Dr. Sethi is a board-certified urologist who has been practicing urology for more than 25 years. He is the founder and CEO of Golden State Urology which has been awarded Center of Excellence for multiple minimally invasive therapies.
November 22, 2022
Amit Vohra, Chief Executive Officer, will participate in the following upcoming investor conferences. The Piper Sandler 34th Annual Healthcare Conference on December 1, 2022, with a presentation at 2:30pm ET; and The Jefferies Virtual Private MedTech Summit on December 6, 2022, with a fireside chat at 11:00am ET. Promaxo is available to meet with investors at the conference; please request a meeting through the conference site.
